Oncolytic viruses: a new class of immunotherapy drugsHoward L. Kaufman, Andrew Zloza|Nature Reviews Drug Discovery|2015Cited by 1.6k
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B. Johnson, Joseph I. Clark, Kristen Spencer et al.|JAMA Oncology|2015Cited by 656
Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Carolina Rosswog, Ying Yu et al.|Genome Biology|2015Cited by 429
Combination immunotherapy: a road mapPatrick A. Ott, Jedd D. Wolchok, F. Stephen Hodi et al.|Journal for ImmunoTherapy of Cancer|2017Cited by 381
Clinical landscape of oncolytic virus research in 2020Nicholas Macedo, Howard L. Kaufman|Journal for ImmunoTherapy of Cancer|2020Cited by 357